PTX
Click for more information
0.00% 4.0¢ prescient therapeutics limited

•As cytarabine is the current standard of care in AML, this...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. psych101
    1,075 Posts.
    lightbulb Created with Sketch. 43
    clock Created with Sketch.
    09/10/17
    15:00
    Post #: 27764847
    •As cytarabine is the current standard of care in AML, this suggests that PTX-200 may potentiate the standard of care, and have significant clinical relevance in the relapse/refractory setting (presentation p. 33)
    Missed this last presentation....,
    Primary standard of care potential, now that’s something to really look forward to.
    PTX Price at posting: 7.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $22.35K 558.4K

Buyers (Bids)

No. Vol. Price($)
6 221774 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 860576 3
View Market Depth
Last trade - 14.51pm 19/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.